4.8 Article

PTC124 is an orally bioavailable compound that promotes suppression of the human CFTR-G542X nonsense allele in a CF mouse model

相关参考文献

注意:仅列出部分参考文献,下载原文获取全部文献信息。
Article Multidisciplinary Sciences

PTC124 targets genetic disorders caused by nonsense mutations

Ellen M. Welch et al.

NATURE (2007)

Review Cell Biology

Early nonsense: mRNA decay solves a translational problem

Nadia Amrani et al.

NATURE REVIEWS MOLECULAR CELL BIOLOGY (2006)

Article Medicine, General & Internal

Gentamicin-induced correction of CFTR function in patients with cystic fibrosis and CFTR stop mutations

M Wilschanski et al.

NEW ENGLAND JOURNAL OF MEDICINE (2003)

Review Genetics & Heredity

The phenotypic consequences of CFTR mutations

RK Rowntree et al.

ANNALS OF HUMAN GENETICS (2003)

Article Critical Care Medicine

Evidence that systemic gentamicin suppresses premature stop mutations in patients with cystic fibrosis

JP Clancy et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2001)

Article Biochemistry & Molecular Biology

A biochemical basis for the inherited susceptibility to aminoglycoside ototoxicity

MX Guan et al.

HUMAN MOLECULAR GENETICS (2000)

Article Critical Care Medicine

A pilot study of the effect of gentamicin on nasal potential difference measurements in cystic fibrosis patients carrying stop mutations

M Wilschanski et al.

AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE (2000)